Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2′-halo daunorubicin analogs

Derek Horton, Waldemar Priebe

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Alkoxyhalogenation of l-rhamnal diacetate with daunomycinone and N-iodosuccinimide afforded 37% of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-2-iodo-α-l-mannopyranosyl)daunomycinone (4, NSC 331,962) and 7% of the β-l-gluco analog (NSC 353,457); a similar procedure with l-fucal diacetate gave 77% of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-2-iodo-α-l-talopyranosyl)daunomycinone (NSC 327,472). Compound 4 showed high activity (T/C 247) and low toxicity in the P-388 lymphocytic leukemia screen in mice.

Original languageEnglish (US)
Pages (from-to)391-396
Number of pages6
JournalCarbohydrate Research
Volume136
Issue numberC
DOIs
StatePublished - Feb 28 1985
Externally publishedYes

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2′-halo daunorubicin analogs'. Together they form a unique fingerprint.

Cite this